Gland Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,695.36 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.02 per cent from ₹1,486.88 crore. This corresponds to a year-on-year *(YoY) growth of 22.49 per cent.
Operating Profit
Operating Profit stands at ₹67.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 27.05 per cent from ₹91.98 crore. This corresponds to a year-on-year *(YoY) decline of 17.48 per cent.
PBDT
PBDT stands at ₹208.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.85 per cent from ₹206.54 crore. This corresponds to a year-on-year *(YoY) growth of 9.09 per cent.
Profit Before Tax
Profit Before Tax stands at ₹362.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.55 per cent from ₹283.91 crore. This corresponds to a year-on-year *(YoY) growth of 20.99 per cent.
Net Profit
Net Profit stands at ₹285.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 55.61 per cent from ₹183.68 crore. This represents a 39.64 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Gland Pharma Ltd News
Gland Pharma Ltd Earnings
- YOY
- QOQ
Gland Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gland Pharma Ltd Research Reports
Gland Pharma Ltd Financial Reports
Gland Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gland Pharma | 0.98% | 0.40% | 1.41% | -11.71% | -17.86% | 12.61% |
| Ajanta Pharma | -0.26% | 0.24% | -0.69% | 9.61% | -3.37% | 1.13% |
| Anthem Bioscienc | 0.79% | -1.40% | -6.08% | -16.26% | -22.20% | -17.75% |
| J B Chemicals & | -1.33% | 0.55% | 2.93% | 8.51% | 3.83% | 6.21% |
| Emcure Pharma | -4.90% | -5.75% | 2.93% | 7.37% | 0.37% | 17.52% |
| Wockhardt | 0.56% | 0.74% | -1.65% | 5.02% | -19.53% | 5.35% |
| Pfizer | 2.51% | 3.14% | -3.83% | -10.60% | -9.84% | 4.95% |
Company Info
Company Information
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : Satyanarayana Murthy Chavali
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI